Ruth Maas is CEO of Autodisplay Biotech GmbH. Prior to founding Autodisplay Biotech, Ruth was group leader at the Institute of Pharmaceutical and Medicinal Chemisty (Working Group Bioanalytik) at Heinrich-Heine University in Düsseldorf.
In 2000, Ruth co-founded the start-up company Pharmacelsus GmbH which is active in the area of pharmacological, biological and bioanalytical test services in vitro and in vivo. Until 2005, she was Head of Cell- and Molecular Biology.
She received her PhD in microbiology from the University of Tubingen, Institute of Microbiology and Biotechnology and held a post doctoral position at the Saarland University Hospital, Institute of Human Genetics.
Joachim Jose is CSO of Autodisplay Biotech GmbH. Besides his activities with Autodisplay Biotech, he is Chair and Full Professor in Pharmaceutical and Medicinal Chemistry at Westfälische Wilhelms-University Münster. Previously, Joachim held various professorship positions at Heinrich-Heine University in Düsseldorf. In 2000, he co-founded Pharmacelcus GmbH which is active in the area of pharmacological, biological and bioanalytical test services in vitro and in vivo.
Joachim received his PhD in microbiology from Saarland University and held a post doctoral position at Max Planck Institute for Infection Biology at Tubingen and Berlin. He earned his habilitation in pharmaceutical and medicinal chemistry.
Gunter Festel is responsible for business development. Besides his activities with Autodisplay Biotech, he is founder and CEO of the advisory and investment firm FESTEL CAPITAL. Prior to that, Gunter was member of the management team and head of the consulting business for the chemical and healthcare industry with Arthur D. Little in Zurich and a consultant with McKinsey. He started his career with Bayer, where he held various management positions in R&D and marketing.
Gunter holds a MA and PhD in chemistry, a BA in business administration, a MA in economics, a PhD in management & economics and an Executive Master of Corporate Finance. At ETH Zurich, Gunter heads a scientific working group focused on start-ups.